Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 23 Jul 2021 for ALEXION PHARMACEUTICALS, INC.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
John T. Mollen: trading record in brief
This profile gathers the share dealings of John T. Mollen in Alexion Pharmaceuticals Inc, where the filings describe the role as board member. Over a trading history stretching from 20 May 2021 to 21 July 2021, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 23 July 2021: a transaction, in Alexion Pharmaceuticals Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John T. Mollen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
15,336 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000071:0
1,962 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000042:0
2 of 2 declarations
